Inhibitors of the Renal Outer Medullary Potassium Channel
申请人:WALSH Shawn P.
公开号:US20150299198A1
公开(公告)日:2015-10-22
The present invention provides compounds of Formula I
and the pharmaceutically acceptable salts thereof, which are inhibitors of the ROMK (Kir1.1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension, heart failure and conditions associated with excessive salt and water retention.
INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL
申请人:Merck Sharp & Dohme Corp.
公开号:EP2925322B1
公开(公告)日:2018-10-24
US9777002B2
申请人:——
公开号:US9777002B2
公开(公告)日:2017-10-03
[EN] INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL<br/>[FR] INHIBITEURS DU CANAL POTASSIQUE MÉDULLAIRE EXTÉRIEUR RÉNAL
申请人:MERCK SHARP & DOHME
公开号:WO2014085210A1
公开(公告)日:2014-06-05
The present invention provides compounds of Formula (I), and the pharmaceutically acceptable salts thereof, which are inhibitors of the ROMK (Kir1.1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension, heart failure and conditions associated with excessive salt and water retention.